1
Workbook 8 · Economic Evaluations
WHO/MSD/MSB 00.2i
Economic
Evaluations
Workbook 8
2
Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2i
WHO
World Health Organization
UNDCP
United Nations International Drug Control Programme
EMCDDA
European Monitoring Center on Drugs and Drug Addiction
World Health Organization, 2000
c
This document is not a formal publication of the World Health Organization (WHO) and all rights are reserved by
the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in
part or in whole but not for sale nor for use in conjunction with commercial purposes. The views expressed in
documents by named authors are solely the responsibility of those authors.
3
Workbook 8 · Economic Evaluations
WHO/MSD/MSB 00.2i
Acknowledgements
The World Health Organization
gratefully acknowledges the con-
tributions of the numerous indi-
viduals involved in the preparation
of this workbook series, including
the experts who provided useful
comments throughout its develop-
ment for the Substance Abuse De-
partment, directed by Dr. Mary
Jansen. Financial assistance was
provided by UNDCP/EMCDDA/
Swiss Federal Office of Public
Health. Alan Ogborne (Canada)
wrote the original text for this
workbook and Brian Rush
(Canada) edited the workbook se-
ries in earlier stages. JoAnne
Epping-Jordan (Switzerland) wrote
further text modifications and edited
the workbook series in later stages.
Munira Lalji (WHO, Substance
Abuse Department) and Jennifer
Hillebrand (WHO, Substance Abuse
Department) also edited the work-
book series in later stages. This
workbook’s case examples were
written by David Cooper (United
Kingdom), Ambros Uchtenhagen et
al. (Switzerland), and edited by
Ginette Goulet (Canada). Maristela
Monteiro (WHO, Substance Abuse
Department) provided editorial input
throughout the development of this
workbook.
4
Evaluation of Psychoactive Substance Use Disorder Treatment
WHO/MSD/MSB 00.2i
5
Workbook 8 · Economic Evaluations
WHO/MSD/MSB 00.2i